36th Annual HDSA Convention: Being Prepared for Huntington’s Disease Emergencies
source: pixabay.com

36th Annual HDSA Convention: Being Prepared for Huntington’s Disease Emergencies

Patient Worthy signed up to cover several sessions at the Huntington's Disease Society of America's (HDSA) 36th Annual Convention, which was held virtually this year. This event features informative presentations…

Continue Reading 36th Annual HDSA Convention: Being Prepared for Huntington’s Disease Emergencies

Mouse Models Prove Success of Gene Therapy for the Treatment of Huntington’s Disease

Research has recently been published in Nature Communications that shows the success of a new gene therapy in the treatment of Huntington's Disease. This therapy, an adeno-associated virus-based gene therapy, was tested…

Continue Reading Mouse Models Prove Success of Gene Therapy for the Treatment of Huntington’s Disease
Neuroscientists Use Genetic Screen to Identify Huntington’s Disease Drug Targets
source: pixabay.com

Neuroscientists Use Genetic Screen to Identify Huntington’s Disease Drug Targets

By Jodee Redmond from In The Cloud Copy Massachusetts Institute of Technology (MIT) researchers have recently announced they have identified hundreds of genes that are required for neuron survival. The…

Continue Reading Neuroscientists Use Genetic Screen to Identify Huntington’s Disease Drug Targets
A Scientist Dedicated Her Life to Researching Huntington’s Disease Before Facing a Diagnosis Herself
source: pixabay.com

A Scientist Dedicated Her Life to Researching Huntington’s Disease Before Facing a Diagnosis Herself

According to a story from Yahoo News, Dr. Nancy Wexler spent around 20 years in Venezuela conducting pivotal research on a deadly rare genetic disorder: Huntington's disease. On Lake Maracaibo,…

Continue Reading A Scientist Dedicated Her Life to Researching Huntington’s Disease Before Facing a Diagnosis Herself
Experimental Treatment for Huntington’s Disease Earns Orphan Drug Designation in the EU
source: pixabay.com

Experimental Treatment for Huntington’s Disease Earns Orphan Drug Designation in the EU

According to a story from globenewswire.com, the biotechnology company Emerald Health Pharmaceuticals Inc., has announced recently that its experimental drug EHP-102 has earned Orphan Drug designation from the European Medicines…

Continue Reading Experimental Treatment for Huntington’s Disease Earns Orphan Drug Designation in the EU
This Huntington’s Disease Trial Could be a Breakthrough–But Not Everyone That Needs Help Can Get In
source: pixabay.com

This Huntington’s Disease Trial Could be a Breakthrough–But Not Everyone That Needs Help Can Get In

According to a story from statnews.com, the family of 46 year old Tammy Stewart has been plagued by Huntington's disease, an ultimately fatal, progressive, degenerative disease that causes decades of…

Continue Reading This Huntington’s Disease Trial Could be a Breakthrough–But Not Everyone That Needs Help Can Get In
New Partnership Aims to Develop Treatment for Huntington’s Disease
rawpixel / Pixabay

New Partnership Aims to Develop Treatment for Huntington’s Disease

According to a story from ncbiotech.org, a new partnership between Vertex Pharmaceuticals and RNA-based therapeutics company Ribometrix aims to develop potential treatments for serious diseases, including Huntington's disease, which is…

Continue Reading New Partnership Aims to Develop Treatment for Huntington’s Disease

New Study Finds Genetic Instability in Brain Cells as Key Trigger for Huntington’s Disease

According to a story from Medical Xpress, a recent study has determined that the onset of Huntington's disease symptoms is triggered by genetic instability in a specific sequence of DNA…

Continue Reading New Study Finds Genetic Instability in Brain Cells as Key Trigger for Huntington’s Disease